Logos Global Management LP lessened its stake in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL – Free Report) by 16.7% in the first quarter, HoldingsChannel.com reports. The firm owned 50,000 shares of the biopharmaceutical company’s stock after selling 10,000 shares during the quarter. Madrigal Pharmaceuticals accounts for 1.7% of Logos Global Management LP’s portfolio, making the stock its […]
Shares of Madrigal Pharmaceuticals, Inc. (MDGL) are declining more than 9 percent on Monday morning trade, continuing a decline since the last couple of days. There have been no corporate announcements today to influence the stock movement.
B. Riley reiterated their neutral rating on shares of Madrigal Pharmaceuticals (NASDAQ:MDGL – Free Report) in a research note issued to investors on Tuesday, Benzinga reports. B. Riley currently has a $224.00 target price on the biopharmaceutical company’s stock. MDGL has been the topic of several other research reports. StockNews.com initiated coverage on Madrigal Pharmaceuticals […]
B. Riley reissued their neutral rating on shares of Madrigal Pharmaceuticals (NASDAQ:MDGL – Free Report) in a report issued on Tuesday, Benzinga reports. They currently have a $224.00 price objective on the biopharmaceutical company’s stock. A number of other brokerages have also commented on MDGL. StockNews.com initiated coverage on Madrigal Pharmaceuticals in a report on […]
Knott David M Jr increased its position in shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL – Free Report) by 75.0% during the first quarter, HoldingsChannel reports. The fund owned 14,000 shares of the biopharmaceutical company’s stock after buying an additional 6,000 shares during the quarter. Madrigal Pharmaceuticals comprises about 1.3% of Knott David M Jr’s portfolio, […]